DOX@Fe/CuTH demonstrates catalytic therapeutic properties triggered by the tumor microenvironment. It amplifies cellular oxidative stress by increasing H2O2 production and depleting GSH simultaneously. This induces mitochondrial dysfunction and down-regulates ATP7A expression, resulting in Cu2+ overload and cellular cuproptosis. The gene discussed is ATP7A; the disease is neoplasm.